These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31379482)

  • 1. Neuronal Circuit-Based Computer Modeling as a Phenotypic Strategy for CNS R&D.
    Geerts H; Barrett JE
    Front Neurosci; 2019; 13():723. PubMed ID: 31379482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
    Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
    CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has the time come for predictive computer modeling in CNS drug discovery and development?
    Geerts H; Spiros A; Roberts P; Carr R
    CPT Pharmacometrics Syst Pharmacol; 2012 Nov; 1(11):e16. PubMed ID: 23835798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's disease.
    Geerts H; Spiros A; Roberts P; Carr R
    Eur J Pharmacol; 2017 Dec; 817():38-45. PubMed ID: 28583429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward.
    Geerts H; Kennis L
    Future Med Chem; 2014; 6(16):1757-69. PubMed ID: 25574530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic screening of the Prestwick library for treatment of Parkinson's tremor symptoms using a humanized quantitative systems pharmacology platform.
    Spiros A; Roberts P; Geerts H
    J Parkinsons Dis; 2013; 3(4):569-80. PubMed ID: 24192755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of quantitative clinical pharmacology to improve early clinical development success in neurodegenerative diseases.
    Geerts H; Gieschke R; Peck R
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):789-795. PubMed ID: 30019953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology.
    Geerts H; Roberts P; Spiros A
    Front Pharmacol; 2015; 6():198. PubMed ID: 26441655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.
    Taylor DL; Gough A; Schurdak ME; Vernetti L; Chennubhotla CS; Lefever D; Pei F; Faeder JR; Lezon TR; Stern AM; Bahar I
    Handb Exp Pharmacol; 2019; 260():327-367. PubMed ID: 31201557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's disease.
    Geerts H; Roberts P; Spiros A; Carr R
    Front Pharmacol; 2013; 4():47. PubMed ID: 23596419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge-driven computational modeling in Alzheimer's disease research: Current state and future trends.
    Geerts H; Hofmann-Apitius M; Anastasio TJ;
    Alzheimers Dement; 2017 Nov; 13(11):1292-1302. PubMed ID: 28917669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development.
    Geerts H; Spiros A; Roberts P; Carr R
    J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):257-65. PubMed ID: 23338980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
    Bai JPF; Earp JC; Pillai VC
    AAPS J; 2019 Jun; 21(4):72. PubMed ID: 31161268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure.
    Cheng L; Qiu Y; Schmidt BJ; Wei GW
    J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):39-50. PubMed ID: 34637069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semi-mechanistic computer simulation of psychotic symptoms in schizophrenia with a model of a humanized cortico-striatal-thalamocortical loop.
    Spiros A; Roberts P; Geerts H
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):107-119. PubMed ID: 28062203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a comprehensive assessment of QSP models: what would it take?
    Androulakis IP
    J Pharmacokinet Pharmacodyn; 2022 Aug; ():. PubMed ID: 35962928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease.
    Roberts P; Spiros A; Geerts H
    Front Pharmacol; 2016; 7():6. PubMed ID: 26869923
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.